title: HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia: description of four cases.
authors.affiliation: Department of Haematology, Hospital Universitario Puerta de Hierro, Majadahonda, Comunidad de Madrid, Spain. rafael.fores@salud.madrid.org.
authors.forename: Rafael
authors.initials: R
authors.lastname: Forés
authors.forename: Nieves
authors.initials: N
authors.lastname: Dorado
authors.forename: Carlos
authors.initials: C
authors.lastname: Vilches
authors.forename: Carmen
authors.initials: C
authors.lastname: Regidor
authors.forename: José A
authors.initials: JA
authors.lastname: García-Marco
authors.forename: Rosario
authors.initials: R
authors.lastname: de Pablo
authors.forename: Almudena
authors.initials: A
authors.lastname: de Laiglesia
authors.forename: Ana
authors.initials: A
authors.lastname: Lario
authors.forename: Miguel
authors.initials: M
authors.lastname: Piris
authors.forename: J Rafael
authors.initials: JR
authors.lastname: Cabrera
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001374:Azacitidine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D006085:Graft Survival; D020544:Graft vs Leukemia Effect; D006680:HLA Antigens / Q000032:analysis* / Q000235:genetics; D006648:Histocompatibility; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D017708:Leukocyte Transfusion; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D014019:Tissue Donors
chemical_list: D006680:HLA Antigens; D003561:Cytarabine; D001374:Azacitidine; D015255:Idarubicin
keywords: acute myeloid leukaemia; cellular therapies; immunotherapy; stem cell transplantation